Abstract
Ten patients with hepatocellular carcinoma successfully underwent transjugular intrahepatic portosystemic shunt (TIPS) without technique-related complications. TIPS was indicated for massive ascites in six cases and ruptures of esophageal varices and hematemesis in four cases. Another two patients with massive ascites developed hepatocellular carcinoma between undergoing TIPS and follow-up observations after 12 and 30 months. In 10 of these 12 patients, the results of TIPS were satisfactory, having obtained good flow in the shunt and effective portal decompression. The gastrointestinal bleeding stopped in all four patients, and the uncontrollable ascites disappeared or decreased in six of the eight patients. Seven out of the 12 patients survived and were followed up for from 2 to 31 months after the TIPS procedure. After TIPS, five patients died due to tumor progression (three patients), hepatic failure (one patient) or acute hepatititis (one patient). In one other patient, the tumor ruptured one month after TIPS was performed. It is concluded that TIPS is a useful and safe treatment for portal hypertension, even in patients with hepatocellular carcinoma as long as it is not located in the puncture route. However, TIPS should be performed only in patients whose tumors have already been controlled by hepatic embolization and/or ethanol injection therapy. Careful follow-up observation is needed after the procedure on a long- term basis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Okuda K (1997) Hepatocellular carcinoma: clinicopathological aspects. J Gastroenterol Hepatol 12(9-10):S314-318
Chen CH, et al. (1998) Characteristics of hepatocellular carcinoma presenting with variceal bleeding. J Gastroenterol Hepatol 13(2):170–174
Oka H, Kurioka N, Kanno T (1990) Prospective detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 12:680–687
Yamada R, Sato M, Kawabata M (1983) Hepatic artery embolization in 120 patients with hepatoma. Radiology 148:397–401
Matsui O, Kadoya M, Yoshikawa J (1993) Small hepatocellular carcinoma: Treatment with subsegmental transcatheter arterial embolization. Radiology 188:79–83
Nomura H, et al. (1999) Rebamipide prevents occurrence of gastric lesions following transcatheter arterial embolization in the hepatic artery. J Gastroenterol Hepatol 14(5):495–499
Bianco S, et al. (1996) Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma. Gut 39(2):325–329
Rosch J, Hanafee WN, Snow H (1969) Transjugular portal venography and radiologic portocaval shunt: an experience study. Radiology 92:588–592
LaBerge JM (1991) Transjugular intrahepatic portosystemic shunt with the Wallstent expandable metallic endoprosthesis. JVIR 16:258–267
Ring EJ, Lake JR, Roberts AP (1992) Percutaneous intrahepatic portosystemic shunts to control variceal bleeding prior to liver transplantation. Ann Intern Med 116:304–309
Yamada R, Sato M, Kishi K (1992) Nippon Acta Radiol 52:1328–1330
Rosch J, Barton RE, Keller FS, et al. (1992) Transjugular Intrahepatic Portosystemic Shunt. Probl Surg 9:502–512
Nakamura K, et al. (1995) Transjugular intrahepatic portosystemic shunt for patients with hepatoma (in Japanese). Nippon Igaku Hoshasen Gakkai Zasshi 55(3):187–189
Uchida B, Putnam J, Buschman R (1987) A traumatic transjugular needle for portal vein puncture in swine. Radiology 163:580–581
Richter GM, Noeldge G, Palmaz JC (1991) The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study. Cardiovasc Intervent Radiol 13:200–207
Zemel G, Katzen BT, Becker GJ (1991) Percutaneous transjugular portosystemic shunt. JAMA 266:309–393
Hauenstein KH, Haag K, Ochs A (1995) The reducing stent: Treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure. Radiology 194:175–179
Burchell AR, Rousselot LM, Panke WF (1968) A seven-year experience with side-toside portocaval shunt for cirrhotic ascites. Ann Surg 168:655–670
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Japan
About this paper
Cite this paper
Nakamura, K. et al. (2000). Transjugular Intrahepatic Portosystemic Shunt for Patients with Hepatocellular Carcinoma. In: Okita, K. (eds) Progress in Hepatocellular Carcinoma Treatment. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67913-4_9
Download citation
DOI: https://doi.org/10.1007/978-4-431-67913-4_9
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67983-7
Online ISBN: 978-4-431-67913-4
eBook Packages: Springer Book Archive